The London School of Hygiene & Tropical Medicine and the Harvard Global Health Institute have convened an Independent Panel on the Global Response to Ebola. The Panel is holding its inaugural meeting in Boston this weekend. It will analyse the major weaknesses in the global health system exposed by the Ebola outbreak, and offer workable recommendations for medium-to-long-term institutional changes required to address them. Read more
The School’s Dr Anna Goodman has been recognised for her research at an event celebrating the achievements of leading women scientists.
She was among 12 scientists in the fields of engineering, physical sciences and medicine, to be presented with a piece of Suffrage Science heirloom jewellery at the award ceremony, which took place at the Royal Society on International Women’s Day. The event was supported by the Medical Research Council, the Royal Society and L’Oréal. Read more
Progress against tuberculosis (TB) is being threatened by drug resistance and all patients with the disease should be tested to find out which treatments they respond to, according to a publication in the BMJ.
As World TB Day approaches with this year’s theme of “reaching, treating and curing everyone”, David Moore, Professor of Infectious Diseases and Tropical Medicine at the London School of Hygiene & Tropical Medicine and co-authors James Millard and Cesar Ugarte-Gil set out current challenges in the diagnosis, treatment and control of multidrug resistant tuberculosis globally. Read more
The next UK Government must trust in NHS staff and local solutions, while nurturing leaders “from ward to board”, according to a leading expert in English health policy and the NHS.
Writing in The Lancet, Nick Black, Professor of Health Services Research at the London School of Hygiene & Tropical Medicine, says that The NHS’s future depends on its staff who need to be “helped and encouraged rather than constantly judged and criticised.” Read more
As the health situation of internally displaced people and refugees in Syria continues to deteriorate, experts in humanitarian crises and conflict from the London School of Hygiene & Tropical Medicine are calling for urgent action on the issue of non-communicable diseases.
Writing in The Lancet Respiratory Medicine with colleagues from the Syrian American Medical Society in the US and the American University of Beirut in Lebanon, Dr Karl Blanchet and Dr Adam Coutts from the School say that while much focus has been on disorders such as leishmaniasis and poliomyelitis, many less visible and untreated non-communicable disorders – such as cardiovascular disease, cancer, diabetes, and mental health issues – are also highly prevalent in Syria and have caused the deaths and disability of thousands. Read more
A new study in Tanzania led by researchers at the London School of Hygiene & Tropical Medicine has provided insights into how gene mutations associated with deficiency in a vital blood enzyme, glucose-6-phosphate dehydrogenase, can protect against malaria.
Edited from an article by Chelsea Radler published by Doctors of the World: Research from the London School of Hygiene & Tropical Medicine at Doctors of the World’s London clinic, published this week, shows that undocumented migrants face multiple barriers, including misinformation and rejection from GP services.
The Keppel Street Bar was recently re-launched as the Pump Handle Bar, in honour of Dr John Snow’s famous research on the water transmission of cholera in Soho. We want the Bar to be a space where staff, students and alumni can relax, socialise and share ideas with each other, so the re-launch offered a great excuse for a programme of low-key, informative events – Talks on Tap!
The London School of Hygiene & Tropical Medicine is a partner in a major TB vaccine initiative consortium, which has been granted a total of 24.6 million euros from the European Commission and other government sources to discover and develop new tuberculosis vaccines.
Hazel Dockrell, Helen Fletcher and Greg Bancroft at the School are leading on three separate projects as part of the TBVAC2020 programme, which uses innovative approaches and preclinical models for vaccine development. Read more